Search research articles
Contact Us
Filters
Showing results (141-150 of 197) with videos related to
Page
of 20
Sort By:
Clinical Rheumatology
|
June 8, 2017
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate
Luisa Costa, Ennio Lubrano, Roberta Ramonda, et al.
Seminars in Arthritis and Rheumatism
|
December 3, 2014
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review
Ennio Lubrano, Antonio Spadaro, Giorgio Amato, et al.
Clinical and Experimental Rheumatology
|
May 30, 2019
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy
Maria Sole Chimenti, Paola Conigliaro, Luca Navarini, et al.
Journal of Clinical Medicine
|
June 26, 2025
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients
Fabiola Atzeni, Cinzia Rotondo, Cesare Siragusano, et al.
Journal of Clinical Medicine
|
April 28, 2023
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium"
Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, et al.
Clinical and Experimental Rheumatology
|
July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry
Maria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
Arthritis Research & Therapy
|
October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
Therapeutic Advances in Musculoskeletal Disease
|
May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
RMD Open
|
February 17, 2021
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, et al.
Annals of the Rheumatic Diseases
|
December 13, 2025
ChatGPT vs rheumatologists: cross-sectional study on accuracy and patient perception of AI-generated information for psoriatic arthritis
Giulio Forte, Daniele Mauro, Maura Raimondi, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 197) with videos related to
Sort By:
Page
of 20
Clinical Rheumatology
|
June 8, 2017
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate
Luisa Costa, Ennio Lubrano, Roberta Ramonda, et al.
Seminars in Arthritis and Rheumatism
|
December 3, 2014
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review
Ennio Lubrano, Antonio Spadaro, Giorgio Amato, et al.
Clinical and Experimental Rheumatology
|
May 30, 2019
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy
Maria Sole Chimenti, Paola Conigliaro, Luca Navarini, et al.
Journal of Clinical Medicine
|
June 26, 2025
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients
Fabiola Atzeni, Cinzia Rotondo, Cesare Siragusano, et al.
Journal of Clinical Medicine
|
April 28, 2023
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium"
Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, et al.
Clinical and Experimental Rheumatology
|
July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry
Maria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
Arthritis Research & Therapy
|
October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
Therapeutic Advances in Musculoskeletal Disease
|
May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
RMD Open
|
February 17, 2021
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, et al.
Annals of the Rheumatic Diseases
|
December 13, 2025
ChatGPT vs rheumatologists: cross-sectional study on accuracy and patient perception of AI-generated information for psoriatic arthritis
Giulio Forte, Daniele Mauro, Maura Raimondi, et al.
Page
of 20